News & Views
Collaborative Model Underpins Drive to meet Challenges
Jun 20 2017
LifeArc, the UK medical research charity previously known as MRC Technology has announced ambitious plans to improve the lives of patients suffering from diseases that present the greatest challenges to medical research. By investing up to £500 million over the next five years, LifeArc will seek to generate, fund and champion innovations in antimicrobials, neuroscience, personalised oncology and respiratory medicine.
The charity will build on its successful model of collaboration by setting up ‘Communities for Impact’, networks that will bring together the best partners to drive medical innovation in specific therapeutic and diagnostic areas. LifeArc’s work has already helped to develop treatments for patients suffering from cancer, rheumatoid arthritis, multiple sclerosis and Crohn’s disease, as well as an improved test for antibiotic resistance.
“Today (June 15) is an important landmark in our history. LifeArc is a new name for an organisation that already has an impressive track record of pioneering new ways to turn the best science into patient treatments. The name LifeArc better reflects what we achieve in being the arc or bridge between great science and its application to help patients,” said Dr Dave Tapolczay, Chief Executive Officer, LifeArc.
LifeArc has also established two new funds for the progression of medical science and these are worth a combined £30 million over four years. The Philanthropic Fund will provide grants to support academic research funded by other medical research charities and organisations, while the Seed Fund will invest in early stage therapeutics and biological research.
Digital Edition
Lab Asia 31.2 April 2024
April 2024
In This Edition Chromatography Articles - Approaches to troubleshooting an SPE method for the analysis of oligonucleotides (pt i) - High-precision liquid flow processes demand full fluidic c...
View all digital editions
Events
Microbiology Society Annual Conference 2024
Apr 08 2024 Edinburgh 2024
Apr 09 2024 Munich, Germany
Apr 10 2024 Helsinki, Finland
Analytica Anacon India & IndiaLabExpo
Apr 15 2024 Mumbai, India
Apr 16 2024 Moscow, Russia